IP Library › Assignment 061621/0152
Patent Assignment
Reel/Frame 061621/0152

Change of Name

Recorded: 2022-10-06 Pages: 3
Assignor
CYDEX, INC.
Executed: 2007-11-19
Assignee
CYDEX PHARMACEUTICALS, INC.
10513 W. 84TH TERRACE, LENEXA, KANSAS, 66214-1643
Covered Properties (3)
DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin
Application: 13/335,780 →
Publication: US 2012/0164184
Dpi Formulation Containing Sulfoalkyl Ether Cyclodextrin
Application: 13/794,652 →
Publication: US 2013/0197105
Dpi Formulation Containing Sulfoalkyl Ether Cyclodextrin
Application: 16/875,855 →
Publication: US 2020/0276314
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 6, 2022
From: PIPKIN, JAMES D.
To: CYDEX, INC.
Reel/Frame 061337/0713 →
Assignment of Assignor's Interest Oct 6, 2022
From: MOSHER, GEROLD L.; HECKER, DOUGLAS B.
To: CYDEX PHARMACEUTICALS, INC.
Reel/Frame 061337/0797 →
Security Interest Oct 18, 2023
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; PFENEX INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065271/0025 →